Search results
Results from the WOW.Com Content Network
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. [9] Stéphane Bancel, the current CEO, was appointed as CEO in 2011. [6] [10] Between 2011 and 2017, Moderna raised $2 billion in venture capital funding. [7] [8]
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.
The company was founded in Cambridge in 1999 by Noubar Afeyan and Ed Kania under the name NewcoGen (short for "new company generation"), but later changed its name to Flagship Ventures, and again in 2016 to Flagship Pioneering. [2]
As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural for investors to wonder about where the biotech will go in the near ...
Overall, the message is that shareholders need to manage their expectations carefully, as the stock may well decline further in the near term. 2. It'll take a few years for its pipeline to deliver ...
When Moderna (NASDAQ:MRNA) posted quarterly results on Nov. 4, it lowered its revenue guidance. This sent MRNA stock down from $350 to below $250. More recently, the emergence of omicron, another ...
Stéphane Bancel (born 20 July 1972) [1] is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux.
For premium support please call: 800-290-4726 more ways to reach us